… and so the phrase they used to frame the process is… “investigational use of an agent in development “. Would that suggest anticipating new trials developing? And the next step is a fresh reexamination by new rapporteurs. An agent in development. 🤔 will slow and steady win the race? Slowly introducing, educating and showing the regulators the new paradigm of treatment. How many more months now will the sellers and short attackers have to bleed the price down and down from here, while we wait.